New York Life Investment Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-22,438
| Closed | -$945K | – | 1426 |
|
|
2023
Q4 | $945K | Sell |
22,438
-482
| -2% | -$20.3K | 0.01% | 672 |
|
|
2023
Q3 | $880K | Sell |
22,920
-3,652
| -14% | -$140K | 0.01% | 648 |
|
|
2023
Q2 | $504K | Sell |
26,572
-3,499
| -12% | -$66.4K | 0.01% | 716 |
|
|
2023
Q1 | $466K | Sell |
30,071
-72,884
| -71% | -$1.13M | 0.01% | 1102 |
|
|
2022
Q4 | $1.83M | Buy |
102,955
+11,612
| +13% | +$206K | 0.02% | 538 |
|
|
2022
Q3 | $510K | Buy |
91,343
+6,708
| +8% | +$37.5K | 0.01% | 724 |
|
|
2022
Q2 | $330K | Buy |
+84,635
| New | +$330K | ﹤0.01% | 1120 |
|